These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22931063)

  • 1. Ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) is increased in cerebrospinal fluid and plasma of patients after epileptic seizure.
    Mondello S; Palmio J; Streeter J; Hayes RL; Peltola J; Jeromin A
    BMC Neurol; 2012 Aug; 12():85. PubMed ID: 22931063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid ubiquitin C-terminal hydrolase as a novel marker of neuronal damage after epileptic seizure.
    Li Y; Wang Z; Zhang B; Zhe X; Wang M; Bai J; Lin T; Zhang S
    Epilepsy Res; 2013 Feb; 103(2-3):205-10. PubMed ID: 22920679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury.
    Mondello S; Linnet A; Buki A; Robicsek S; Gabrielli A; Tepas J; Papa L; Brophy GM; Tortella F; Hayes RL; Wang KK
    Neurosurgery; 2012 Mar; 70(3):666-75. PubMed ID: 21937927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats.
    Liu MC; Akinyi L; Scharf D; Mo J; Larner SF; Muller U; Oli MW; Zheng W; Kobeissy F; Papa L; Lu XC; Dave JR; Tortella FC; Hayes RL; Wang KK
    Eur J Neurosci; 2010 Feb; 31(4):722-32. PubMed ID: 20384815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of ubiquitin C-terminal hydrolase-L1 enzyme levels in patients with epilepsy.
    Yasak IH; Yilmaz M; GÖnen M; Atescelik M; Gurger M; Ilhan N; Goktekin MC
    Arq Neuropsiquiatr; 2020 Jul; 78(7):424-429. PubMed ID: 32756860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Cerebrospinal Fluid Ubiquitin C-Terminal Hydrolase L1 as a Biomarker of Human Acute Traumatic Spinal Cord Injury.
    Stukas S; Gill J; Cooper J; Belanger L; Ritchie L; Tsang A; Dong K; Streijger F; Street J; Paquette S; Ailon T; Dea N; Charest-Morin R; Fisher CG; Dhall S; Mac-Thiong JM; Wilson JR; Bailey C; Christie S; Dvorak MF; Wellington C; Kwon BK
    J Neurotrauma; 2021 Aug; 38(15):2055-2064. PubMed ID: 33504255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids.
    Brophy GM; Mondello S; Papa L; Robicsek SA; Gabrielli A; Tepas J; Buki A; Robertson C; Tortella FC; Hayes RL; Wang KK
    J Neurotrauma; 2011 Jun; 28(6):861-70. PubMed ID: 21309726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury.
    Papa L; Akinyi L; Liu MC; Pineda JA; Tepas JJ; Oli MW; Zheng W; Robinson G; Robicsek SA; Gabrielli A; Heaton SC; Hannay HJ; Demery JA; Brophy GM; Layon J; Robertson CS; Hayes RL; Wang KK
    Crit Care Med; 2010 Jan; 38(1):138-44. PubMed ID: 19726976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study.
    Mondello S; Papa L; Buki A; Bullock MR; Czeiter E; Tortella FC; Wang KK; Hayes RL
    Crit Care; 2011 Jun; 15(3):R156. PubMed ID: 21702960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of ubiquitin carboxy-terminal hydrolase-L1 in cerebrospinal fluid with clinical severity in a cohort of patients with Guillain-Barré syndrome.
    Nagamine S; Fujiwara Y; Shimizu T; Kawata A; Wada K; Isozaki E; Kabuta T
    Neurol Sci; 2015 Jun; 36(6):921-6. PubMed ID: 25739945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
    Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
    J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats.
    Huang XJ; Glushakova O; Mondello S; Van K; Hayes RL; Lyeth BG
    J Neurotrauma; 2015 Aug; 32(16):1179-89. PubMed ID: 25763798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.
    Diaz-Arrastia R; Wang KK; Papa L; Sorani MD; Yue JK; Puccio AM; McMahon PJ; Inoue T; Yuh EL; Lingsma HF; Maas AI; Valadka AB; Okonkwo DO; Manley GT;
    J Neurotrauma; 2014 Jan; 31(1):19-25. PubMed ID: 23865516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating glial fibrillary acidic protein and ubiquitin carboxy-terminal hydrolase-L1 as markers of neuronal damage in children with epileptic seizures.
    Elhady M; Youness ER; AbuShady MM; Nassar MS; Elaziz AA; Masoud MM; Foudaa FK; Elhamed WAA
    Childs Nerv Syst; 2021 Mar; 37(3):879-884. PubMed ID: 33044615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury.
    Takala RS; Posti JP; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Kyllönen A; Maanpää HR; Tallus J; Hossain MI; Coles JP; Hutchinson P; van Gils M; Menon DK; Tenovuo O
    World Neurosurg; 2016 Mar; 87():8-20. PubMed ID: 26547005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.
    Mondello S; Constantinescu R; Zetterberg H; Andreasson U; Holmberg B; Jeromin A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):382-7. PubMed ID: 24507721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum ubiquitin C-terminal hydrolase-L1 levels in patients with carbon monoxide poisoning.
    Pang L; Wu Y; Dong N; Xu DH; Wang DW; Wang ZH; Li XL; Bian M; Zhao HJ; Liu XL; Zhang N
    Clin Biochem; 2014 Jan; 47(1-2):72-6. PubMed ID: 24080464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum ubiquitin C-terminal hydrolase L1 as a biomarker for traumatic brain injury: a systematic review and meta-analysis.
    Li J; Yu C; Sun Y; Li Y
    Am J Emerg Med; 2015 Sep; 33(9):1191-6. PubMed ID: 26087705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of ubiquitin C-terminal hydrolase-L1 levels in serum and urine of patients with white matter lesions.
    Li Y; Sun Y; Li J; Wang Z; Lin Y; Tang L; Xia D; Zheng T; Yang X; Sha L; Sun CK
    J Neurol Sci; 2015 Oct; 357(1-2):215-21. PubMed ID: 26232084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Clinical Outcomes 7-10 Years after Severe Traumatic Brain Injury: Exploring the Prognostic Utility of the IMPACT Lab Model and Cerebrospinal Fluid UCH-L1 and MAP-2.
    Svingos AM; Robicsek SA; Hayes RL; Wang KK; Robertson CS; Brophy GM; Papa L; Gabrielli A; Hannay HJ; Bauer RM; Heaton SC
    Neurocrit Care; 2022 Aug; 37(1):172-183. PubMed ID: 35229233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.